New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Clinic-based community program shows promise in addressing food insecurity and improving health

Clinic-based community program shows promise in addressing food insecurity and improving health

The FISH (Food Insecurity and its Sequalae on Health) Study, led by Tiffany Wesley Ardoin, MD, FACP, Assistant Professor of Clinical Medicine at LSU Health New Orleans' Baton Rouge Regional Campus
World medicine November 09,2023
Clinic-based community program shows promise in addressing food insecurity and improving health

Clinic-based community program shows promise in addressing food insecurity and improving health

The FISH (Food Insecurity and its Sequalae on Health) Study, led by Tiffany Wesley Ardoin, MD, FACP, Assistant Professor of Clinical Medicine at LSU Health New Orleans' Baton Rouge Regional Campus
World medicine November 09,2023
Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

The RAF/MEK and FAK inhibitor combination avutometinib (VS-6766) plus defactinib (VS-6063) represents a novel area of exploration that has displayed clinical activity and a manageable safety profile i
World medicine November 09,2023
Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

The RAF/MEK and FAK inhibitor combination avutometinib (VS-6766) plus defactinib (VS-6063) represents a novel area of exploration that has displayed clinical activity and a manageable safety profile i
World medicine November 09,2023
TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 demonstrated sustained antitumor activity in all but 1 patient with relapsed/refractory follicular lymphoma, regardless of CD20 status, as well as number and type of prior therapy, according t
World medicine November 09,2023
TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 demonstrated sustained antitumor activity in all but 1 patient with relapsed/refractory follicular lymphoma, regardless of CD20 status, as well as number and type of prior therapy, according t
World medicine November 09,2023
AI-based method shows promise for precision medicine

AI-based method shows promise for precision medicine

Artificial intelligence, AI, which finds patterns in complex biological data could eventually contribute to the development of individually tailored healthcare. Researchers at Linköping University in
World medicine November 09,2023
AI-based method shows promise for precision medicine

AI-based method shows promise for precision medicine

Artificial intelligence, AI, which finds patterns in complex biological data could eventually contribute to the development of individually tailored healthcare. Researchers at Linköping University in
World medicine November 09,2023
SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

The second line may be the optimal setting for patients with HR-positive, HER2-negative advanced breast cancer to receive CDK4/6 inhibitors, according to findings from the phase 3 SONIA trial (NCT0342
World medicine November 09,2023
SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

The second line may be the optimal setting for patients with HR-positive, HER2-negative advanced breast cancer to receive CDK4/6 inhibitors, according to findings from the phase 3 SONIA trial (NCT0342
World medicine November 09,2023
New AI-based method reduces latency in neurofeedback by 50-fold

New AI-based method reduces latency in neurofeedback by 50-fold

Researchers from HSE University and the Artificial Intelligence Research Institute (AIRI) have successfully lowered the latency between a change in brain activity and the presentation of the correspon
World medicine November 09,2023
New AI-based method reduces latency in neurofeedback by 50-fold

New AI-based method reduces latency in neurofeedback by 50-fold

Researchers from HSE University and the Artificial Intelligence Research Institute (AIRI) have successfully lowered the latency between a change in brain activity and the presentation of the correspon
World medicine November 09,2023
IL-17: The molecule that could revolutionize autoimmune and cancer treatments

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The family of interleukin-17 (IL-17) includes six molecules that respond to infection, in addition to participating in various physiological and pathological processes. A new paper inSignal Tran
World medicine November 09,2023
IL-17: The molecule that could revolutionize autoimmune and cancer treatments

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The family of interleukin-17 (IL-17) includes six molecules that respond to infection, in addition to participating in various physiological and pathological processes. A new paper inSignal Tran
World medicine November 09,2023
Ruxolitinib Improves Spleen Volume, TSS in Myelofibrosis Irrespective of Anemia, Transfusion Status

Ruxolitinib Improves Spleen Volume, TSS in Myelofibrosis Irrespective of Anemia, Transfusion Status

Ruxolitinib (Jakafi) was found to improve spleen volume and tumor symptom score (TSS) in patients with myelofibrosis, irrespective of their anemia and transfusion status, according to data from a post
World medicine November 09,2023
Ruxolitinib Improves Spleen Volume, TSS in Myelofibrosis Irrespective of Anemia, Transfusion Status

Ruxolitinib Improves Spleen Volume, TSS in Myelofibrosis Irrespective of Anemia, Transfusion Status

Ruxolitinib (Jakafi) was found to improve spleen volume and tumor symptom score (TSS) in patients with myelofibrosis, irrespective of their anemia and transfusion status, according to data from a post
World medicine November 09,2023
Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

In a recent review published inImmunity, researchers reviewed tumor-immunity cycle data.Study:The cancer-immunity cycle: Indication, genotype, and immunotype. Image Credit:Alpha Taur
World medicine November 09,2023
Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

In a recent review published inImmunity, researchers reviewed tumor-immunity cycle data.Study:The cancer-immunity cycle: Indication, genotype, and immunotype. Image Credit:Alpha Taur
World medicine November 09,2023
Are migraines linked to gut health and chronic non-communicable diseases?

Are migraines linked to gut health and chronic non-communicable diseases?

In a recent review published inNutrients, researchers examine the Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).Study:Linking Migraine to Gut Dysbiosis
World medicine November 09,2023
Are migraines linked to gut health and chronic non-communicable diseases?

Are migraines linked to gut health and chronic non-communicable diseases?

In a recent review published inNutrients, researchers examine the Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).Study:Linking Migraine to Gut Dysbiosis
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com